Prof. Mojžiš Ján, DVM, DrSc.
Research/art/teacher profile
Date of last update: 22.10.2026
I. Basic information
| I.1 Surname |
Mojžiš |
|---|---|
| I.2 Given name |
Ján |
| I.3 Degrees |
Prof. , DVM, DrSc. |
| I.4 Year of birth |
1955 |
| I.5 Name of the workplace |
University of Veterinary Medicine and Pharmacy in Košice, External Teachers' Workplace |
| I.6 Address of the workplace |
Komenského 73, 041 81 Košice, Slovak Republic |
| I.8 E-mail address | jan.mojzis@uvlf.sk |
| I.9 University staff register / partner university profile | https://www.portalvs.sk/regzam/detail/14977 |
| I.11 ORCID iD | 0000-0002-7974-4525 |
II. Higher education and further qualification growth
| Institution | Year | Study field and programme | |
|---|---|---|---|
| Second degree higher education | Veterinary College in Košice | 1980 | general veterinary medicine |
| Third degree higher education | Veterinary College in Košice | 1991 | biochemistry |
| Habilitation procedure | Pavol Jozef Šafárik University in Košice, Faculty of Medicine | 1996 | pharmacology |
| Inaugural procedure | Pavol Jozef Šafárik University in Košice, Faculty of Medicine | 2003 | pharmacology |
| Doctor of Sciences (DrSc.) | Pavol Jozef Šafárik University, Faculty of Medicine | 2012 | pharmacology |
III. Current and previous employment
| Occupation | Institution | Year |
|---|---|---|
Professor | avol Jozef Šafárik University, Faculty of Medicine, Institute of Pharmacology | 2003 – to date |
Assotiate professor | Pavol Jozef Šafárik University, Faculty of Medicine, Institute of Pharmacology | 1996 – 2003 |
Researcher | Pavol Jozef Šafárik University, Faculty of Medicine, Institute of Pharmacology | 1988 – 1996 |
Researcher | Military veterinary training and research institute, Košice | 1980 – 1988 |
IV. Development of pedagogical, professional, language, digital and other skills
| Activity | Institution | Year |
|---|---|---|
Military veterinary training and research institute, Košice | 1984 | |
Veterinary College in Košice | 1980 |
V. Overview of activities within the teaching career at the university
Academic year: 2026/2027
V.1. Overview of taught profile courses
No records yet.
V.2. Responsibility for the delivery, development and quality assurance of study programmes
No records yet.
V.3. Responsibility for the development and quality of habilitation and inauguration fields
No records yet.
V.4. Overview of supervised theses
| Bachelor | Master | Doctoral | |
|---|---|---|---|
| Currently supervised theses | 0 | 0 | 3 |
| Defended theses | 0 | 4 | 15 |
V.5. Overview of other taught courses
No records yet.
VI. Overview of research/artistic/other outputs
The last six completed calendar years: 2020–2025. The current year is excluded.
VI.1. Overview of research/artistic/other outputs and citations
| Total | Over the last six years | |
|---|---|---|
| VI.1.1 Number of research/artistic/other outputs | 610 | 118 |
| VI.1.2 Number of outputs registered in Web of Science or Scopus | 195 | 55 |
| VI.1.3 Number of citations corresponding to research/artistic/other outputs | 2329 | 1195 |
| VI.1.4 Number of citations registered in Web of Science or Scopus | 1988 | 1134 |
| VI.1.5 Number of invited lectures at international and national level | 0 | 0 |
VI.2. The most significant research/artistic/other outputs
| 1. | ADC: Mojzis J., Varinska L., Mojzisova G., Kostova I, Mirossay L.: antiangogenic effect of flavonoids and chalcones. Pharmacol. Res. 57, 259-265, 2008 (IF=3,929; Q1) cit. 207x |
|---|---|
| 2. | ADC: Lukáč M, Mojžiš J, Mojžišová G, Mrva M, Ondriska F, Valentová J, Lacko I, Bukovský M, Devínsky F, Karlovská J.: Dialkylamino and nitrogen heterocyclic analogues of hexadecylphosphocholine and cetyltrimetylammonium bromide: Effect of phosphate group and environment of the ammonium cation on their biological activity. Eur J Med Chem. 44, 4970-4977, 2009. (IF=3,269; Q2) cit. 22x |
| 3. | ADC: Pilatova M, Varinska L, Perjesi P, Sarissky M, Mirossay L, Solar P, Ostro A, Mojzis J.: In vitro antiproliferative and antiangiogenic effects of synthetic chalcone analogues. Toxicol In Vitro. 24, 1347-1355, 2010. (IF=2,959; Q1) cit. 41x |
| 4. | ADC: Cizmarikova M, Wagnerova M, Schonova L, Habalova V, Kohut A, Linkova A, Sarissky M, Mojzis J, Mirossay L, Mirossay A.: MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome. Pharmacogenomics J. 10, 62-69, 2010. (IF=4,306; Q1) cit. 73x |
| 5. | ADC: Pilátová M., Šarišský M., Kutschy P., Miroššay A., Mezencev R., Čurillová, Z., Suchý, M., Monde, K., Mirossay, L., Mojžiš J.: Cruciferous phytoalexins: Antiproloferative effects in T-Jurkat leukemic cells. Leuk. Res. 29, 415-421, 2005. (IF=2,636; Q2) cit. 38x. |
VI.3. The most significant research/artistic/other outputs over the last six years
| 1. | ADC: Mirossay L, Varinská L, Mojžiš J. Antiangiogenic Effect of Flavonoids and Chalcones: An Update. Int J Mol Sci. 19, pii: E27., 2018 (IF=3,226; Q1) cit. 48 x |
|---|---|
| 2. | ADC: Kubatka P, Kello M, Kajo K, Kruzliak P, Výbohová D, Mojžiš J, Adamkov M, Fialová S, Veizerová L, Zulli A, Péč M, Statelová D, Grančai D, Büsselberg D. Oregano demonstrates distinct tumour-suppressive effects in the breast carcinoma model. Eur J Nutr. 56, 1303-1316, 2017 (IF=3,467; Q1). cit. 21x |
| 3. | ADC: Kapinova, A., Stefanicka, P., Kubatka, P., Zubor, P., Uramova, S., Kello, M., Mojzis, J., Blahutova, D., Qaradakhi, T., Zulli, A., Caprnda, M., Danko, J., Lasabova, Z., Busselberg, D., Kruzliak, P.: Are plant-based functional foods better choice against cancer than single phytochemicals? A critical review of current breast cancer research. Biomed Pharmacother. 96, 1465–1477, 2017 (IF= 2,326; Q1) cit. 51 x |
| 4. | ADM: Kello M, Takac P, Kubatka P, Kuruc T, Petrova K, Mojzis J. Oxidative Stress-Induced DNA Damage and Apoptosis in Clove Buds-Treated MCF-7 Cells. Biomolecules 10, pii: E139, 2020 (IF=4,649; Q1) cit. 8 x |
| 5. | ADM: Takac P, Kello M, Vilkova M, Vaskova J, Michalkova R, Mojzisova G, Mojzis J. Antiproliferative Effect of Acridine Chalcone Is Mediated by Induction of Oxidative Stress. Biomolecules 10, pii: E345, 2020 (IF=4,649; Q1) cit. 12 x |
VI.4. The most significant citations corresponding to research/artistic/other outputs
| 1. | Citovaný dokument: Mojzis J., Varinska L., Mojzisova G., Kostova I, Mirossay L.: Antiangogenic effect of flavonoids and chalcones. Pharmacol. Res. 57, 259-265, 2008 (IF=3,929; Q1 - SJR) cit. 207x Oh |
|---|---|
| 2. | Citovaný dokument: ADC: Solárová Z., Mojžiš J., Solár P.: Hsp90 inhibitor as a sensitizer of cancer cells to different therapies. Int J Oncol 46: 907-926, 2015 (IF=2,773; Q2); cit. 52x Ohlas: ADC: Pawar, Mercy; Busov, Boris; Chandrasekhar, Aaruran; et al. FAS apoptotic inhibitory molecule 2 is a stress-induced intrinsic neuroprotective factor in the retina Cell Death Differ 24, 1799-1810, 2017 (IF=8,291; Q1) |
| 3. | Citovaný dokument: Cizmarikova M, Wagnerova M, Schonova L, Habalova V, Kohut A, Linkova A, Sarissky M, Mojzis J, Mirossay L, Mirossay A.: MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome. Pharmacogenomics J. 10, 62-69, 2010. (IF=4,306; Q1) cit. 73x Ohlas: ADC: Aogi K., Iwata H., Masuda N., Mukai H., Yoshida M., Rai Y., Taguchi K., Sasaki Y., Takashima, S.: A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer. Ann Oncol 23, 1441-1448, 2012. (IF=7,384; Q1) |
| 4. | Citovaný dokument: Varinska L, Gal P, Mojzisova G, Mirossay L, Mojzis J.: Soy and Breast Cancer: Focus on Angiogenesis. Int J Mol Sci. 16, 11728-11749, 2015 (IF= 3.257; Q1). cit. 102x; Ohlas: ADC: Molina, Luis; Bustamante, Felipe A.; Bhoola, Kanti D.; et al. Possible role of phytoestrogens in breast cancer via GPER-1/GPR30 signaling. Clin Sci 132, 2583-2598, 2018 (IF=5,22; Q1) |
| 5. | Citovaný dokument: Mirossay L, Varinská L, Mojžiš J. Antiangiogenic Effect of Flavonoids and Chalcones: An Update. Int J Mol Sci. 19, pii: E27., 2018 (IF=3,226; Q1) cit. 48x; Ohlas: ADC: Zheng, Dan; Zhao, Jingyang; Tao, Yinghua; Liu, J; Wang, LY; He, J; Lei, JD; Liu, KF. pH and glutathione dual responsive nanoparticles based on Ganoderma lucidum polysaccharide for potential programmable release of three drugs. Chem Engin J 389, Article No. 124418, 2020 (IF=13, 273; Q1) |
VI.5. Participation in conducting or leading the most important projects over the last six years
| 1. | APVV–0408–12: Galektíny a angiogenéza. 2013-2017: Zodpovedný riešiteľ: prof. MVDr. Ján Mojžiš, DrSc. |
|---|---|
| 2. | APVV-16-0446; Bunkové interakcie v nádorovom mikroprostredí a ich farmakologické ovplyvnenie. 2017-2021: Zodpovedný riešiteľ od roku 2018 - prof. MVDr. Ján Mojžiš, DrSc. |
| 3. | VEGA 1/0753/17; Vplyv prírodných látok na nádorové mikroprostredie. 2017-2020. Zodpovedný riešiteľ: prof. MVDr. J. Mojžiš, DrSc. |
| 4. | VEGA 1/0539/21; Fibroblasty a nádorové mikroprostredie: bunkové interakcie a ich farmakologické ovplyvnenie. 2021-2024. Zodpovedný riešiteľ: prof. MVDr. J. Mojžiš, DrSc. |
| 5. | Štrukturálne fondy: OPENMED Kód ITMS2014+:313011V455. Zodpovedný riešiteľ aktivity 7.1: prof. MVDr. J. Mojžiš, DrSc. |
VII. Overview of organizational experience related to higher education and research/artistic/other activities
| Position / activity | Institution | Year |
|---|---|---|
Vice-chairman of the PJŠU Attestation Commission in Košice | Pavol Jozef Šafárik University in Košice | 2015 – to date |
Member of the APVV commission for medical sciences | Ministry of Education, Science, Research and Sports of the Slovak Republic | 2015 – to date |
Member of the commission no. 9. VEGA | Ministry of Education, Science, Research and Sports of the Slovak Republic | 2013 – 2020 |
Member of Scietifical Board | Pavol Jozef Šafárik University in Košice | 2011 – 2015 |
Member of the committee of the Slovak Pharmacological Society | SLS | 2010 – to date |
Member of the committee for the defense of dissertations in the field of Pharmacology; Member of the committee for the defense of dissertations in the field of Molecular Cytology | Pavol Jozef Šafárik University in Košice | 2004 – to date |
VIII. Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study
No records yet.
IX. Other relevant facts
|
1. in 1996 and 1998 - first author and co-author of papers that were evaluated as the best publications at the Faculty of Medicine UPJŠ 2. 1997 - co-author of a textbook of pharmacology, evaluated as the best monograph at the Faculty of Medicine UPJŠ 3. 2000 - award of a professional society for a set of papers 4. 2001 - author of the best monograph at LF UPJŠ 5. 2002 - co-author of a publication that placed 2nd at LF UPJŠ 6. 2005 - co-author of a publication that placed 2nd at LF UPJŠ 7. 2013 – Vladimír Novotný Award for the best original work for the year 2012 in the journal Psychiatry for practice (co-author) 8. 2015 – Rector's Award of UPJŠ in Košice for scientific research and publication activity 9. Co-guarantor of EU structural funds projects (coordinator Prof. MUDr. L. Mirosay, DrSc.): Network of excellence workplaces for oncology (SEPO) Building infrastructure in the center of excellence SEPO-II 10. Member of the editorial board of Folia Medica Cassoviensia, Transactions of the Universities of Košice, International Journal of Current Chemistry 11. Chairman of the organizing committee of the 62nd Farmakologický dni, Košice, 2012 12. Reviewer of about 100 articles sent to scientific journals. 13. Hirsch index 28 |